Hill & Knowlton names Barton as new healthcare head

Hill & Knowlton has hired Ketchum's Sally Barton to head its New York healthcare practice. Barton succeeds John Quick as director of the New York health and pharmaceutical practice. Quick has left the company.
At Ketchum, where she reported to healthcare chief David Catlett, Barton worked on the launch of Genentech's Avastin and Tysabri, which is co-promoted by Elan and Biogen IDEC. Hill & Knowlton healthcare brands include Actonel, from Procter & Gamble and Sanofi-Aventis, and Sankyo's Benicar and Welchol, along with the Eisai PR business.
You must be a registered member of MMM to post a comment.

Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.